<code id='20EB65FD43'></code><style id='20EB65FD43'></style>
    • <acronym id='20EB65FD43'></acronym>
      <center id='20EB65FD43'><center id='20EB65FD43'><tfoot id='20EB65FD43'></tfoot></center><abbr id='20EB65FD43'><dir id='20EB65FD43'><tfoot id='20EB65FD43'></tfoot><noframes id='20EB65FD43'>

    • <optgroup id='20EB65FD43'><strike id='20EB65FD43'><sup id='20EB65FD43'></sup></strike><code id='20EB65FD43'></code></optgroup>
        1. <b id='20EB65FD43'><label id='20EB65FD43'><select id='20EB65FD43'><dt id='20EB65FD43'><span id='20EB65FD43'></span></dt></select></label></b><u id='20EB65FD43'></u>
          <i id='20EB65FD43'><strike id='20EB65FD43'><tt id='20EB65FD43'><pre id='20EB65FD43'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:6

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          focus

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Novo acquires Inversago for up to $1 billion
          Novo acquires Inversago for up to $1 billion

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesFreshoffofthenewsthatitsdrugWegovymaynotjusthelppeoplelosew

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          An inside look at PIPEs, biotech's buzzy new financing tool

          MollyFerguson/STATBiotechisawashinPIPEs.Thenumbersbehindtheseprivatelynegotiatedpurchasesofpublic-co